James E. Lingeman MD, FACS

Dr. Lingeman is well-known nationally and internationally for his interest in the area of kidney stone disease and minimally invasive urologic techniques. Dr. Lingeman performed the first percutaneous stone removal procedure in the State of Indiana in 1983 and performed the first ESWL treatment in the United States at Indiana University Health/Methodist Hospital in Indianapolis in 1984. Currently, Dr. Lingeman and Indiana University Health/Methodist Hospital are widely recognized for their expertise in both state-of-the-art techniques for kidney stone removal and also in understanding and preventing kidney stone formation. Dr. Lingeman holds several grants from the National Institutes of Health studying extracorporeal shock wave lithotripsy and kidney stone formation. In addition to kidney stone disease, Dr. Lingeman is also well known for his work with other minimally invasive urologic techniques. He performed the first laparoscopic nephrectomy in the State of Indiana and also introduced the use of the holmium laser for urolithiasis and benign prostatic hyperplasia (BPH). The first holmium laser prostatectomy (HoLEP) in the United States was performed at Methodist Hospital by Dr. Lingeman in 1998.

Dr. Lingeman is currently Co-Director of the International Kidney Stone Institute. He is Chairman of the Board of the Methodist Research Institute and is currently a member of the Board of Directors of Indiana University Health, a healthcare system comprised of 19 hospitals in the State of Indiana. Dr. Lingeman is a Professor of Urology at Indiana University School of Medicine. He is a past president of the Indiana State Urologic Society and past president of the North Central Section of the American Urological Association. Dr. Lingeman is president of the Endourology Society. He is a member of the American Association of Genitourinary Surgeons (AAGUS). Dr. Lingeman is the author of over 300 peer review scientific publications.